Advances in genetics and treatment protocols lead to significant progress in leukemia and myeloproliferative disorders.
D006801:Humans; D007223:Infant; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000235:genetics; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D011505:Protein-Tyrosine Kinases